Article
BH4 responsiveness associated to a PKU mutation with decreased binding affinity for the cofactor.
Clinica chimica acta; international journal of clinical chemistry - 1 May 2007
Aguado Cristina, Pérez Belen, García M José, Bélanger-Quintana Amaya, Martínez-Pardo Mercedes, Ugarte Magdalena, Desviat Lourdes R
Abstract excerpt
BACKGROUND: Tetrahydrobiopterin (BH4), cofactor of phenylalanine hydroxylase, can be used to treat a subset of phenylketonuria (PKU) patients as it results in a reduction in blood phenylalanine levels. The molecular basis of the response appears to be multifactorial. METHOD: A standard BH4 loading test (20 mg/kg) was performed. Genotyping was performed by DGGE and sequencing analysis. Expression analysis of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
